ZEB1 drives prometastatic actin cytoskeletal remodeling by downregulating miR-34a expression
Young‐Ho Ahn(Ewha Womans University), Jonathan M. Kurie(The University of Texas MD Anderson Cancer Center), Don L. Gibbons(The University of Texas MD Anderson Cancer Center), Deepavali Chakravarti(The University of Texas MD Anderson Cancer Center), Josephine A. Wright(The University of Adelaide), Chad J. Creighton(Baylor College of Medicine), Alexander Pertsemlidis(The University of Texas at San Antonio Health Science Center), Gregory J. Goodall(Centre for Cancer Biology), Philip A. Gregory(University of South Australia), Henry P. Adams(The University of Texas MD Anderson Cancer Center), Zain H. Rizvi(The University of Texas MD Anderson Cancer Center), Elsa R. Flores(Moffitt Cancer Center)
Cited by 153
Related Papers
UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
|Neoplasia|2017|6.5k
UALCAN: An update to the integrated cancer data analysis platform
|Neoplasia|2022|2.5k
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
|Proceedings of the National Academy of Sciences|2009|1.4k